Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Clinical trial NCT05970627 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05970627
Sponsor: Yu jiren
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Stomach Adenocarcinoma of Esophagogastric Junction Epstein-Barr Virus-Associated Gastric Carcinoma

Start date: 2023-07-28
Primary completion: 2026-07-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.